Company Filing History:
1 out of 832,912 Years Active: 2013
Title: Innovations of Haiyan Shang in Cancer Treatment
Introduction
Haiyan Shang is a notable inventor based in Dalian, China. He has made significant contributions to the field of cancer treatment through his innovative research and development of pharmaceutical compounds. His work focuses on the synthesis and application of cyclin-dependent protein kinases (Cdks) inhibitors, which are crucial in the fight against cancer.
Latest Patents
Haiyan Shang holds a patent for a series of cyclin-dependent protein kinases (Cdks) inhibitors, specifically flavonoid organic amine derivatives. The patent outlines a preparation method that involves using Baicalein (or Wogonin) as a lead compound, mixing it with formaldehyde solution and organic amine compounds in a specific molar ratio. The process includes adding methanol and reacting at temperatures between 50-70°C. The resulting product boasts a purity of not less than 97% by weight. This innovative compound has shown a remarkable increase in activity, being 50 times more effective than Baicalin in inhibiting Cdks. It selectively induces apoptosis in proliferative phase cancer cells while sparing normal cells, positioning it as a promising anticancer drug.
Career Highlights
Throughout his career, Haiyan Shang has demonstrated a commitment to advancing cancer treatment through his research. His innovative approach to synthesizing Cdks inhibitors has the potential to lead to the development of high-efficiency and low-toxicity anti-cancer and AIDS drugs. His work is characterized by a rich source of raw materials, a simple preparation process, and a clear metabolic mechanism.
Collaborations
Haiyan Shang has collaborated with notable colleagues in his field, including Shixuan Zhang and Yongming Bao. Their combined expertise contributes to the advancement of research in cancer therapeutics.
Conclusion
Haiyan Shang's contributions to the field of cancer treatment through his innovative patents and research are commendable. His work not only enhances our understanding of cancer therapies but also paves the way for the development of effective and safe treatment options.